nach oben

Acta Neurochirurgica

Erschienen in:

17.01.2019 | Case Report - Brain Tumors

Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease—a case report and literature review

Erschienen in: Acta Neurochirurgica | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Hemangioblastomas (HB) are benign tumors of the central nervous system (CNS) that can appear sporadic or as part of von Hippel-Lindau (VHL) disease. It is often curable with surgical resection, but upon relapse, the disease exhibits a treatment-refractory course.

Case report

A patient treated for sporadic cerebellar HB relapsed 12 years post-surgery. She developed disseminated disease throughout the CNS, including leptomeningeal manifestations. Repeat surgery and craniospinal radiation therapy were unsuccessful.

Conclusion

This case is in line with previous publications on disseminated non-VHL HB. Available treatment options are inefficient, emphasizing the need for improved understanding of HB biology to identify therapeutic targets.

Akimoto J, Fukuhara H, Suda T, Nagai K, Hashimoto R, Michihiro K (2014) Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease. Surg Neurol Int 5:145. https://doi.org/10.4103/2152-7806.142321 CrossRefPubMedPubMedCentral

Amelot A, Bouazza S, Polivka M, George B, Bresson D (2015) Sporadically second localization of cerebellar hemangioblastoma in sella turcica mimicking a meningioma with no associated von Hippel-Lindau disease. Br J Neurosurg 29:589–591. https://doi.org/10.3109/02688697.2015.1016894 CrossRefPubMed

Böhling T, Plate K, Haltia M, Litalo K, Neumann H (2000) von Hippel-Lindau disease and capillary haemangioblastoma in World Health Organization Classification of Tumors Pathology, genetics of tumours of the nervous system. 223–6 edn., Lyon

Bruner J, Tien R, McLendon R (1998) Tumors of vascular origin. In Russel and Rubinstein’s pathology of tumors of the nervous system. 6th edn., London

Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629–642. https://doi.org/10.1148/radiology.194.3.7862955 CrossRefPubMed

Chung SY, Jeun SS, Park JH (2014) Disseminated hemangioblastoma of the central nervous system without von Hippel-Lindau disease. Brain Tumor Res Treat 2:96–101. https://doi.org/10.14791/btrt.2014.2.2.96 CrossRefPubMedPubMedCentral

de la Monte SM, Horowitz SA (1989) Hemangioblastomas: clinical and histopathological factors correlated with recurrence. Neurosurgery 25:695–698CrossRefPubMed

Gijtenbeek JM, Jacobs B, Sprenger SH, Eleveld MJ, van Kessel AG, Kros JM, Sciot R, van Calenbergh F, Wesseling P, Jeuken JW (2002) Analysis of von hippel-Lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. J Neurosurg 97:977–982. https://doi.org/10.3171/jns.2002.97.4.0977 CrossRefPubMed

Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S (2003) Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol 136:194–196CrossRefPubMed

10.

Hande AM, Nagpal RD (1996) Cerebellar haemangioblastoma with extensive dissemination. Br J Neurosurg 10:507–511CrossRefPubMed

11.

Hasselblatt M, Jeibmann A, Gerss J, Behrens C, Rama B, Wassmann H, Paulus W (2005) Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases. Neuropathol Appl Neurobiol 31:618–622CrossRefPubMed

12.

Kato M, Ohe N, Okumura A, Shinoda J, Nomura A, Shuin T, Sakai N (2005) Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Neuro-Oncol 72:267–270. https://doi.org/10.1007/s11060-004-2244-7 CrossRef

13.

Kim HR, Suh YL, Kim JW, Lee JI (2009) Disseminated hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Korean Med Sci 24:755–759. https://doi.org/10.3346/jkms.2009.24.4.755 CrossRefPubMedPubMedCentral

14.

Kruizinga RC, van Marion DM, den Dunnen WF, de Groot JC, Hoving EW, Oosting SF, Timmer-Bosscha H, Derks RP, Cornelissen C, van der Luijt RB, Links TP, de Vries EG, Walenkamp AM (2016) Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma. Familial Cancer 15:607–616. https://doi.org/10.1007/s10689-016-9879-3 CrossRefPubMedPubMedCentral

15.

Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z (1998) Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504–508PubMed

16.

Lightfoot NJ, Lucas PG, Finnis ND (2007) Disseminated haemangioblastoma without evidence of the von Hippel-Lindau syndrome or haemangioblastomatosis--a case report and clinico-pathological correlation. Clin Neurol Neurosurg 109:305–310. https://doi.org/10.1016/j.clineuro.2006.12.007 CrossRefPubMed

17.

Mandahl N (1992) Human cytogenetics - a practical approach: Vol. II. Malignancy and acquired abnormalities, vol II. IRL Press, Oxford

18.

Mohan J, Brownell B, Oppenheimer DR (1976) Malignant spread of haemangioblastoma: report on two cases. J Neurol Neurosurg Psychiatry 39:515–525CrossRefPubMedPubMedCentral

19.

Muscarella LA, Bisceglia M, Galliani CA, Zidar N, Ben-Dor DJ, Pasquinelli G, la Torre A, Sparaneo A, Fanburg-Smith JC, Lamovec J, Michal M, Bacchi CE (2018) Extraneuraxial hemangioblastoma: a clinicopathologic study of 10 cases with molecular analysis of the VHL gene. Pathol Res Pract 214:1156–1165. https://doi.org/10.1016/j.prp.2018.05.007 CrossRefPubMed

20.

Niemela M, Maenpaa H, Salven P, Summanen P, Poussa K, Laatikainen L, Jaaskelainen J, Joensuu H (2001) Interferon alpha-2a therapy in 18 hemangioblastomas. Clin Cancer Res 7:510–516PubMed

21.

Omar AI (2012) Bevacizumab for the treatment of surgically unresectable cervical cord hemangioblastoma: a case report. J Med Case Rep 6:238. https://doi.org/10.1186/1752-1947-6-238 CrossRefPubMedPubMedCentral

22.

Raghavan R, Krumerman J, Rushing EJ, White CL III, Chason DP, Watson ML, Coimbra C (2000) Recurrent (nonfamilial) hemangioblastomas involving spinal nerve roots: case report. Neurosurgery 47:1443–1448CrossRefPubMed

23.

Ramachandran R, Lee HS, Matthews B, Shatzel A, Tihan T (2008) Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair. Arch Pathol Lab Med 132:104–108. https://doi.org/10.1043/1543-2165(2008)132[104:IELHAP]2.0.CO;2

24.

Russell DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system. 5th edn., London

25.

Seystahl K, Weller M, Bozinov O, Reimann R, Rushing E (2014) Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncol Res Treat 37:209–212CrossRefPubMed

26.

International Standing Committee on Human Cytogenetic Nomenclature, Shaffer LG, Slovak ML, Campbell LJ (2009) ISCN 2009: an international system for human cytogenetic nomenclature. Karger, Basel; Unionville, CT

27.

Shankar GM, Taylor-Weiner A, Lelic N, Jones RT, Kim JC, Francis JM, Abedalthagafi M, Borges LF, Coumans JV, Curry WT, Nahed BV, Shin JH, Paek SH, Park SH, Stewart C, Lawrence MS, Cibulskis K, Thorner AR, Van Hummelen P, Stemmer-Rachamimov AO, Batchelor TT, Carter SL, Hoang MP, Santagata S, Louis DN, Barker FG, Meyerson M, Getz G, Brastianos PK, Cahill DP (2014) Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta neuropathologica communications 2:167. https://doi.org/10.1186/s40478-014-0167-x CrossRefPubMed

28.

Taieb D, Barlier A, Yang C, Pertuit M, Tchoghandjian A, Rochette C, Zattara-Canoni H, Figarella-Branger D, Zhuang Z, Pacak K, Metellus P (2016) Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. J Neuro-Oncol 126:473–481. https://doi.org/10.1007/s11060-015-1983-y CrossRef

29.

Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, Yamamoto S, Ichimura K, Nakatomi H, Ueki K, Aburatani H, Saito N (2017) Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro-Oncology 19:1228–1236. https://doi.org/10.1093/neuonc/nox034 CrossRefPubMedPubMedCentral

30.

Tohyama T, Kubo O, Kusano R, Miura N, Himuro H (1990) A case of hemangioblastoma with subarachnoid dissemination. No Shinkei Geka 18:83–88PubMed

31.

Weil RJ, Vortmeyer AO, Zhuang Z, Pack SD, Theodore N, Erickson RK, Oldfield EH (2002) Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. J Neurosurg 96:775–787. https://doi.org/10.3171/jns.2002.96.4.0775 CrossRefPubMed

Titel: Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease—a case report and literature review
Publikationsdatum: 17.01.2019
Erschienen in: Acta Neurochirurgica / Ausgabe 2/2019
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-019-03800-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease—a case report and literature review

Abstract

Background

Case report

Conclusion

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Case report

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study

Thank you list 2018

Post-partum posterior reversible encephalopathy syndrome requiring decompressive craniectomy: case report and review of the literature

Modified unilateral approach for mid-third giant bifalcine meningiomas: resection using an oblique surgical trajectory and falx window

Efficiency and complications of Woven EndoBridge (WEB) devices for treatment of larger, complex intracranial aneurysms—a single-center experience

Statin use in patients undergoing carotid artery endarterectomy: still much to be uncovered

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie